The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lifecore Biomedical Inc
F:LDE
|
US |
|
Banco Santander SA
F:BSDK
|
ES |
|
A
|
Agripure Holdings PCL
SET:APURE
|
TH |
|
Co-Diagnostics Inc
NASDAQ:CODX
|
US |
|
D
|
Del Monte Corp
F:FDM
|
KY |
|
E
|
Equinor ASA
SWB:DNQA
|
NO |
|
I
|
IPG Photonics Corp
SWB:IPF
|
US |
|
S
|
Shin-Etsu Chemical Co Ltd
OTC:SHECF
|
JP |
|
S
|
Surteco Group SE
XMUN:SUR
|
DE |
|
B
|
Bitcoin Group SE
DUS:ADE
|
DE |
|
V
|
Vertex Pharmaceuticals Inc
DUS:VX1
|
US |
|
Promotora de Informaciones SA
MAD:PRS
|
ES |
|
B
|
Bumi Resources Minerals Tbk PT
XMUN:BUR
|
ID |
|
A
|
Avis Budget Group Inc
XMUN:CUCA
|
US |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
B
|
Bank of China Ltd
OTC:BACHF
|
CN |
|
Corporate Travel Management Ltd
ASX:CTD
|
AU |
|
V
|
Vinci SA
DUS:SQU
|
FR |
|
A
|
Autodesk Inc
F:AUD
|
US |
|
Compania de Minas Buenaventura SAA
F:MBU
|
PE |
|
Windar Photonics PLC
F:7WP
|
DK |
|
I
|
Infineon Technologies AG
XMUN:IFX
|
DE |
|
Swisscom AG
SIX:SCMN
|
CH |
|
L
|
LSI Industries Inc
F:LS2
|
US |
Lifecore Biomedical Inc (LDE)’s 12-month stock price forecast through November 2027 has a consensus target of €5.17, implying 7% downside. The forecast is based on price targets from 5 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
LDE is 5.17 EUR with a low forecast of 4.54 EUR and a high forecast of 5.92 EUR.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more